Topic · 3 episodes
AI in Drug Discovery and Science
Every Onpode episode on AI in Drug Discovery and Science.
Episodes
Insilico just compressed 4.5-year drug discovery into 9 months using AI—here's what that meansInsilico Medicine's Pharma.AI platform compressed drug discovery from an industry-standard 4.5 years to 9 months — but that covers only 10–20% of total development time. No AI-designed drug has received regulatory approval anywhere. Rentosertib, Insilico's lead candidate, is in Phase II trials with results still pending.
Anthropic just released Claude Science aimed directly at the pharma and research industryAnthropic launched Claude Science on June 30, 2026, connecting 60-plus scientific databases to Claude Opus 4.8 and Sonnet — no new model. The real tension: Anthropic simultaneously announced an internal drug discovery program using ex-Genentech scientists from its $400M Coefficient Bio acquisition, making it both vendor and competitor to pharma customers.
Anthropic CEO Amodei just declared AI turns drug discovery into scalable pattern-matchingAnthropic launched Claude Science, an internal drug discovery program, on June 30 — but AI drug discovery has logged $60 billion invested, 175 programs in trials, and zero FDA approvals. Pattern-matching accelerates candidate selection; it does not shorten the 10-to-15-year clinical gauntlet. Discovery was never the bottleneck.